发明名称 |
Humanized anti-α 9 integrin antibodies and the uses thereof |
摘要 |
The present invention provides humanized antibodies that immunospecifically recognize human α9 integrin. Some of these antibodies inhibit the biological functions of the α9 integrin, thereby exhibiting therapeutic effects on various disorders or diseases that are associated with α9 integrin, including cancer, e.g., the growth and metastasis of a cancer cell, and inflammatory diseases, e.g., rheumatoid arthritis, osteoarthritis, hepatitis, bronchial asthma, fibrosis, diabetes, arteriosclerosis, multiple sclerosis, granuloma, an inflammatory bowel disease (ulcerative colitis and Crohn's disease), an autoimmune disease, and so forth. |
申请公布号 |
US8821863(B2) |
申请公布日期 |
2014.09.02 |
申请号 |
US200912812455 |
申请日期 |
2009.01.13 |
申请人 |
Gene Techno Science Co., Ltd.;Kaken Pharmaceutical Co. |
发明人 |
Kumar Shankar;Tso J. Yun;Tsurushita Naoya;Kon Shigeyuki |
分类号 |
A61K39/42;C07K16/00;C07K16/28 |
主分类号 |
A61K39/42 |
代理机构 |
Morrison & Foerster, LLP |
代理人 |
Morrison & Foerster, LLP |
主权项 |
1. A humanized antibody or an antigen-binding fragment thereof that immunospecifically recognizes human α9integrin, comprising:
(i) a H-chain comprising the amino acid sequence of SEQ ID NO:29; and (ii) a L-chain comprising the amino acid sequence of SEQ ID NO:31. |
地址 |
Hokkaido JP |